Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Acne Patients with Oily Skin

Emil Tanghetti; Michael  Gold; Neil Sadick; Fran Cook-Bolden; Leon  Kircik; Linda Stein Gold; Stephen Tyring; James Del Rosso; Eric Guenin

doi:10.25251/skin.5.supp.71

Emil Tanghetti

Center for Dermatology and Laser Surgery, Sacramento, CA

Michael Gold

Tennessee Clinical Research Center, Nashville, TN

Neil Sadick

Sadick Dermatology, New York, NY

Fran Cook-Bolden

Weill Cornell Medical College, New York, NY

Leon Kircik

Mount Sinai

Linda Stein Gold

Henry Ford Health System, Detroit, MI, USA

Stephen Tyring

University of Texas Health Science Center, Houston, TX

James Del Rosso

JDR Dermatology Research/Thomas Dermatology, Las Vegas, NV, USA

Eric Guenin

Ortho Dermatologics

Keywords

acne, tazarotene, oily skin

Abstract

N/A

References

1. Moradi Tuchayi S, et al. Nat Rev Dis Primers. 2015;1:15029.

2. Endly DC, et al. J Clin Aesthet Dermatol. 2017;10(8):49-55.

3. Roh M, et al. Br J Dermatol. 2006;155(5):890-894.

4. Pappas A, et al. Dermatoendocrinol. 2013;5(2):319-324.

5. Leyden J, et al. Dermatol Ther (Heidelb). 2017;7(3):293-304.

6. Kang S, et al. J Am Acad Dermatol. 2005;52(2):268-274.

7. Tanghetti EA, et al. J Drugs Dermatol. 2020;19(3):272-279.

8. Martin AR, et al. Clin Exp Dermatol. 2001;26(5):380-385.

9. Tanghetti EA, et al. J Dermatol Treat. 2021;32(4):391-398

Poster PDF

Published

Nov 5, 2021

DOI https://doi.org/10.25251/skin.5.supp.71

How to Cite

[1]

Tanghetti, E., Gold, M. , Sadick, N., Cook-Bolden, F., Kircik, L. , Stein Gold, L., Tyring, S., Del Rosso, J. and Guenin, E. 2021. Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Acne Patients with Oily Skin. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s71. DOI:https://doi.org/10.25251/skin.5.supp.71.

Issue

Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®)

Section

Acne & Rosacea

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

Hilary E Baldwin, Lawrence Green, Leon Kircik, Ashlie M Caronia, Eric Guenin, Efficacy and Safety of a Novel Tazarotene 0.045% Lotion in Females and Males With Moderate-to-Severe Acne , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Linda Stein Gold, Christopher E Griffiths, Anna M Tallman, Philip M Brown, Mark Lebwohl, Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Improvements in Quality of Life and Clinical Efficacy in Two Pivotal Phase 3 Trials , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Todd Schlesinger, Mark Lebwohl, James Del Rosso, Vishal A. Patel, Leon Kircik, April Armstrong, Brian Berman, Darrell Rigel, Siva Narayanan, Volker Koscielny, Ismail Kasujee, Neal Bhatia, Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study) , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
James Del Rosso, H. Chih-ho Hong, Leon Kircik, Melinda Gooderham, Mark Lebwohl, Kim Papp, Linda Stein Gold, Adelaide Hebert, Melissa Seal, David Krupa, David Chu, Patrick Burnett, David Berk, Robert Higham, Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient Response From the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
Neal Bhatia, April W Armstrong, Todd Schlesinger, Leon Kircik, Brian Berman, Mark Lebwohl, Darrell Rigel, Vishal A Patel, James Del Rosso, Ayman Grada, Siva Narayanan, Ismail Kasujee, An Expert Panel Questionnaire for Assessing Patient-Reported and Clinician-Reported Outcomes in Actinic Keratosis , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Jonette Keri, Leon Kircik, Lawrence Green, Glynis Ablon, William Werschler, Emil Tanghetti, Zoe Draelos, Eric Guenin, Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)
James Del Rosso, Linda Stein Gold, Sandra Marchese Johnson, Maria Jose Rueda, Hilary Baldwin, Edward L Lain, Megan Landis, Marta Rendon, Emil Tanghetti, Jonathan Weiss, Efficacy and Saftey of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Doxycycline in Subjects with Severe Inflammatory Acne (Non-Nodulocystic) that are Candidates for Oral Isotretinoin , SKIN The Journal of Cutaneous Medicine: Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas
James Del Rosso, Antibiotic Resistance Considerations of Importance to Clinical Dermatologists , SKIN The Journal of Cutaneous Medicine: Vol. 1 No. 2 (2017)
Linda Stein Gold, Kim Papp, Charles Lynde, Edward Lain, Melinda Gooderham, Sandra Johnson, Nabil Kerrouche, Gregor Schafer, Concurrent Administration of Ivermectin 1% Cream with Brimonidine 0.33% Gel Improves Efficacy and Tolerability in the Treatment of Moderate-to-Severe Rosacea , SKIN The Journal of Cutaneous Medicine: Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas
Linda Stein Gold, James Q Del Rosso, Leon Kircik, Neal D Bhatia, Deirdre Hooper, Walter Nahm, Iain Stuart, Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)

<< < 4 5 6 7 8 9 10 11 12 13 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Most read articles by the same author(s)